7,376.86

+23.13

+0.31%

51,285.73

-237.33

-0.46%

24,579.42

+264.43

+1.09%

2,754.11

+24.22

+0.89%

4.8590

+0.0220

+0.45%

25.64

-2.54

-9.01%

4,074.90

-38.60

-0.94%

75,635.00

-128.84

-0.17%

Crude Oil Dec 26

90.83

+0.31

+0.34%

US Private Equity

10,772.76

+11.83

+0.11%

OTC Markets OTCPK - Delayed Quote USD

Adaptimmune Therapeutics plc (ADAPY)

0.0200 +0.0010 (+5.26%)

At close: November 6 at 4:00:00 PM EST

How Immunocore Is Expanding Beyond Its Rare-Cancer Drug Kimmtrak

Zacks 3mo ago

IMCR

ADAPY
+5.26%
BMY
Flagship Pioneering Appoints Adrian Rawcliffe as CEO-Partner and CEO of Etiome

PR Newswire 9mo ago

ADAPY
+5.26%
Adaptimmune Announces Changes to Board and Executive Leadership Team

TMX Newsfile 11mo ago

ADAP

ADAPY
+5.26%

Mobilize your Website

View Site in Mobile | Classic

Share by: